Department of Physiology and Biophysics, State University of New York at Buffalo, Buffalo, NY, USA.
Gene Targeting and Transgenic Resource, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Nat Protoc. 2021 Aug;16(8):3954-3980. doi: 10.1038/s41596-021-00565-7. Epub 2021 Jul 2.
Naive human pluripotent stem cells (hPSCs) can be used to generate mature human cells of all three germ layers in mouse-human chimeric embryos. Here, we describe a protocol for generating mouse-human chimeric embryos by injecting naive hPSCs converted from the primed state. Primed hPSCs are treated with a mammalian target of rapamycin inhibitor (Torin1) for 3 h and dissociated to single cells, which are plated on mouse embryonic fibroblasts in 2iLI medium, a condition essentially the same for culturing mouse embryonic stem cells. After 3-4 d, bright, dome-shaped colonies with mouse embryonic stem cell morphology are passaged in 2iLI medium. Established naive hPSCs are injected into mouse blastocysts, which produce E17.5 mouse embryos containing 0.1-4.0% human cells as quantified by next-generation sequencing of 18S ribosomal DNA amplicons. The protocol is suitable for studying the development of hPSCs in mouse embryos and may facilitate the generation of human cells, tissues and organs in animals.
幼稚态人类多能干细胞(hPSCs)可用于在鼠-人嵌合胚胎中生成源自所有三个胚层的成熟人类细胞。在此,我们描述了一种通过注射由初始态重编程的幼稚态 hPSC 来生成鼠-人嵌合胚胎的方案。初始态 hPSC 用哺乳动物雷帕霉素靶蛋白抑制剂(Torin1)处理 3 小时并解离为单细胞,这些细胞在含有 2iLI 培养基的小鼠胚胎成纤维细胞上培养,该条件与培养小鼠胚胎干细胞的条件基本相同。3-4 天后,具有小鼠胚胎干细胞形态的明亮、圆顶状集落在 2iLI 培养基中传代。已建立的幼稚态 hPSC 被注射到小鼠囊胚中,这些囊胚产生的 E17.5 代小鼠胚胎中含有 0.1-4.0%的人类细胞,这可通过对 18S 核糖体 DNA 扩增子进行下一代测序来定量。该方案适用于研究 hPSC 在小鼠胚胎中的发育情况,并且可能有助于在动物中生成人类细胞、组织和器官。